News 
Coin Information 
About us 
EY, an international assurance, tax, and advisory company, has partnered with artificial intelligence (AI) firm Sensyne Health and enterprise blockchain company Guardtime to tie medicine payments to clinical treatment success and patient satisfaction, in a so-called outcomes-based contracting.
According to its press release, the collaboration will work towards the expansion of the Health Outcomes Assessment platform, the first of its kind in the healthcare industry, to enable the platform to scale faster, resulting in “fairer reimbursement and access to novel treatments for patients.”
Under the collaboration, Sensyne Health will use AI to clinically assess the impact of medicine on the health of patients. On the other hand, Guardtime will allow transparent data to be shared between pharmaceutical companies and health providers and provide an audit trail for each viewed and used data. It will use its HSX bridge software built on the KSI blockchain.
“Guardtime’s KSI blockchain technology will help ensure patient-level data visibility without compromising data privacy, helping to ensure all participants can collaborate securely and with confidence,” Guardtime CEO Mike Gault said.
In addition, EY will see itself bringing independent contract assessment, contract management, and automated business process experience and help deal with real-world outcomes-based contracts while maintaining transparency and trust.
“We are delighted to be working to deliver the triple win: with life sciences companies increasing access to medicines, health care providers achieving greater efficiency and effectiveness and, most importantly, more patients getting better health outcomes,” Dan Matthews, EY EMEIA Life Sciences Leader, said.
Just recently, Arizona Care Network will soon allow patients with diabetes to use a healthcare blockchain network to manage the disease and optimize care with their physicians and families, using a platform collaborated by Solve.Care and Boehringer Ingelheim.
Comment 0